With Prof. Rui Zhang (Surgery, UMN), we are proud to be funded by FDA to develop a scalable, generalizable, and explainable AI-powered informatics framework, CardioOnco-AI, on the curation and modeling of real-world data for individualized prediction of cardiotoxicity among breast cancer survivors. (Grant title: CardioOnco-AI: AI-empowered cardiotoxicity risk prediction among breast cancer survivors using multi-site real-world data; Amount: $1.5M)